Project Details
Description
An Open-Label, Long-Term Extension Study of the Safety and Efficacy of A Long-acting Human Growth Hormone (VRS-317) in Children with Growth Hormone Deficiency
| Status | Finished |
|---|---|
| Effective start/end date | 12/19/13 → 12/31/22 |
Funding
- VERSARTIS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.